External Service
CDMO service
As a national high-tech enterprise, The First Condor Group has a hard-core consultant team and research and development team, a GMP-like laboratory of more than 10,000 square meters and a complete quality control system. The R&D personnel have rich practical experience in cell drug research and development, clinical research, etc., and the quality control personnel have the background of a large pharmaceutical factory. The preparation of UCMSC(umbilical cord mesenchymal stem cell) passed the quality review inspection of National Institutes for Food and Drug Control.

The First Condor Group takes advantage of its own advantages in cell drug research and development and production, to undertake the process development and production functions of cell drug companies, so that cell drug companies can focus more on cell drug research and development, and develop more and better cell drugs for the benefit of the majority of patients.

The CDMO service mainly includes the following aspects:

Development and production of stem cells and immune cells (including CAR-T cells)

Detectionstem cells, immune cells (including CAR-T cells)

Biological potency, pharmacology and independent analysis

Process flow, transportation and storage, quality control and cooperative research

Rapid Approval Advisory Service for cell drugs

Cell technology transfer services

Molecular pathology, single-cell analysis, and tumor cell analysis